当前位置:首页 > Adis Insight >

Adis Insight:2024探索生物类似药的潜力历史成就与未来前景研究报告(英文版)

  • 2024年06月05日
  • 50 金币

Biosimilars are safe and effective treatment options for many illnesses, such as chronic skinand bowel diseases (like psoriasis, irritable bowel syndrome, Crohn’s disease, and colitis),arthritis, kidney conditions, and cancer. These medicines are very close in structure andfunction to biologic medicines and increase access to lifesaving medications at potentiallylower costs. They are highly similar to a biologic medication already approved by aregulatory body – the original biologic (also c

  • 关注微信

猜你喜欢